Objective: To study the effects in systemic lupus erythaematosus (SLE) of B cell directed therapy with rituximab, a chimeric monoclonal antibody directed at CD20+ B cells, without concomitant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback